Table 4.
Reader 1 | Reader 2 | Inter-reader variability* | |||||||
---|---|---|---|---|---|---|---|---|---|
Sens (%) | Spec (%) | PPV (%) | NPV (%) | Sens (%) | Spec (%) | PPV (%) | NPV (%) | ||
Renal, esophageal and hepatic cancers (n = 43) | |||||||||
WB and SPECT | 20 | 74 | 29 | 64 | 34 | 85 | 55 | 71 | 0.66 |
2D SPECT–CT | 78 | 98 | 95 | 89 | 90 | 99 | 97 | 95 | 0.88 |
3D SPECT–CT | 79 | 99 | 97 | 90 | 90 | 99 | 97 | 95 | 0.89 |
The other cancers (n = 275) | |||||||||
WB and SPECT | 85 | 78 | 75 | 87 | 87 | 84 | 81 | 91 | 0.82 |
2D SPECT–CT | 93 | 99 | 98 | 94 | 96 | 99 | 99 | 97 | 0.91 |
3D SPECT–CT | 93 | 98 | 97 | 95 | 96 | 99 | 99 | 97 | 0.91 |
Total (n = 318) | |||||||||
WB and SPECT | 78 | 77 | 72 | 83 | 82 | 84 | 79 | 86 | 0.72 |
2D SPECT–CT | 91 | 99 | 98 | 94 | 95 | 99 | 99 | 96 | 0.90 |
3D SPECT–CT | 91 | 98 | 97 | 94 | 95 | 99 | 98 | 96 | 0.89 |
Sens sensitivity, Spec specificity, PPV positive predictive value, NPV negative predictive value
* Weighted kappa value based on the four-point scale